目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug
1.2.2. Mode of Administration
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Phenylketonuria Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis

Chapter 4. Phenylketonuria Treatment Market: Drug Business Analysis
4.1. Drug Market Share, 2024 & 2030
4.2. Drug Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
4.4. Kuvan
4.4.1. Kuvan market, 2018 - 2030 (USD Million)
4.5. Palynziq
4.5.1. Palynziq market, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Phenylketonuria Treatment Market: Mode of Administration Business Analysis
5.1. Mode of Administration Market Share, 2024 & 2030
5.2. Mode of Administration Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Mode of Administration, 2018 to 2030 (USD Million)
5.4. Oral Administration
5.4.1. Oral administration market, 2018 - 2030 (USD Million)
5.5. Parenteral Administration
5.5.1. Parenteral administration market, 2018 - 2030 (USD Million)

Chapter 6. Phenylketonuria Treatment Market: Regional Estimates & Trend Analysis by Drug and Mode of Adinistration
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Denmark phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Sweden phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Norway phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. South Korea phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamics
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. BioMarin
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Synlogic
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Travere Therapeutics, Inc.
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. DAIICHI SANKYO COMPANY, LIMITED.
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Codexis, Inc.
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. SOM BIOTECH
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Homology Medicines, Inc. (Q32 Bio Inc.)
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global phenylketonuria treatment market, by region, 2018 - 2030 (USD Million)
Table 4 Global phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 5 Global phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 6 North America Phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 7 North America phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 8 North America phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 9 U.S. phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 10 U.S. phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 11 Canada phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 12 Canada phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 13 Mexico phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 14 Mexico phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 15 Europe phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 16 Europe phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 17 Europe phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 18 UK phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 19 UK phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 20 Germany phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 21 Germany phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 22 France phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 23 France phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 24 Italy phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 25 Italy phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 26 Spain phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 27 Spain phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 28 Denmark phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 29 Denmark phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 30 Sweden phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 31 Sweden phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 32 Norway phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 33 Norway phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 34 Asia Pacific phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 36 Asia Pacific phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 37 Japan phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 38 Japan phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 39 China phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 40 China phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 41 India phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 42 India phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 43 Australia phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 44 Australia phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 45 South Korea phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 46 South Korea phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 47 Thailand phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 48 Thailand phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 49 Latin America phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 51 Latin America phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 52 Brazil phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 53 Brazil phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 54 Argentina phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 55 Argentina phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 59 South Africa phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 60 South Africa phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 63 UAE phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 64 UAE phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 65 Kuwait phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 66 Kuwait phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Phenylketonuria treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Drug outlook (USD Million)
Fig. 10 Mode of administration outlook
Fig. 11 Competitive landscape
Fig. 12 Phenylketonuria treatment market dynamics
Fig. 13 Phenylketonuria treatment market: Porter’s five forces analysis
Fig. 14 Phenylketonuria treatment market: PESTLE analysis
Fig. 15 Phenylketonuria treatment market: Drug segment dashboard
Fig. 16 Phenylketonuria treatment market: Drug market share analysis, 2024 & 2030
Fig. 17 Kuvan market, 2018 - 2030 (USD Million)
Fig. 18 Palynziq market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Phenylketonuria treatment market: Mode of administration segment dashboard
Fig. 21 Phenylketonuria treatment market: Mode of administration market share analysis, 2024 & 2030
Fig. 22 Oral administration market, 2018 - 2030 (USD Million)
Fig. 23 Parenteral administration market, 2018 - 2030 (USD Million)
Fig. 24 Phenylketonuria treatment market revenue, by region
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 Regional marketplace: Key takeaways
Fig. 27 North America phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 28 U.S. country dynamics
Fig. 29 U.S. phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 30 Canada country dynamics
Fig. 31 Canada phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 32 Mexico country dynamics
Fig. 33 Mexico phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 34 Europe phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 35 UK country dynamics
Fig. 36 UK phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 37 Germany country dynamics
Fig. 38 Germany phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 39 France country dynamics
Fig. 40 France phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 41 Italy country dynamics
Fig. 42 Italy phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 43 Spain country dynamics
Fig. 44 Spain phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 45 Denmark country dynamics
Fig. 46 Denmark phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 47 Sweden country dynamics
Fig. 48 Sweden phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 49 Norway country dynamics
Fig. 50 Norway phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 52 Japan country dynamics
Fig. 53 Japan phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 54 China country dynamics
Fig. 55 China phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 56 India country dynamics
Fig. 57 India phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 58 Australia country dynamics
Fig. 59 Australia phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 60 South Korea country dynamics
Fig. 61 South Korea phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 62 Thailand country dynamics
Fig. 63 Thailand phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 64 Latin America phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 65 Brazil country dynamics
Fig. 66 Brazil phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 67 Argentina country dynamics
Fig. 68 Argentina phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 69 MEA phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 70 South Africa country dynamics
Fig. 71 South Africa phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia country dynamics
Fig. 73 Saudi Arabia phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 74 UAE country dynamics
Fig. 75 UAE phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 76 Kuwait Key country dynamics
Fig. 77 Kuwait phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 78 Company categorization
Fig. 79 Company market position analysis
Fig. 80 Strategic framework